<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zanvit, Peter</style></author><author><style face="normal" font="default" size="100%">McGlinchey, Kelly</style></author><author><style face="normal" font="default" size="100%">Fazenbaker, Christine</style></author><author><style face="normal" font="default" size="100%">Luo, Weichuan</style></author><author><style face="normal" font="default" size="100%">Pezold, Jessica</style></author><author><style face="normal" font="default" size="100%">Hoover, Clare</style></author><author><style face="normal" font="default" size="100%">Cobbold, Mark</style></author><author><style face="normal" font="default" size="100%">Moody, Gordon</style></author><author><style face="normal" font="default" size="100%">Bosco, Emily</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2023-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">A369-A369</style></pages><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2023-SITC2023.0325</style></doi><volume><style face="normal" font="default" size="100%">11</style></volume><issue><style face="normal" font="default" size="100%">Suppl 1</style></issue><abstract><style  face="normal" font="default" size="100%">Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.</style></abstract></record></records></xml>